The Lancet - Articles and news items

Janssen Pharmaceuticals Logo

Phase 2 COSMOS study results published in The Lancet demonstrate efficacy and safety of Janssen’s once-daily imeprevir

Industry news / 29 July 2014 / Janssen

… in all oral 12-week combination with sofosbuvir for genotype 1 chronic hepatitis C.

Amgen logo

The Lancet Oncology publishes results of XGEVA® (denosumab)

Industry news, News / 16 July 2013 / Amgen

Phase 2 study reports safety and efficacy results in patients with giant cell tumor of bone…

Novo Nordisk Logo

Two phase 3 studies on ultra-long-acting insulin degludec published in The Lancet

Industry news / 23 April 2012 / Novo Nordisk

Two studies show a significant reduction in the rates of nocturnal hypoglycaemia by 25%, compared to insulin glargine…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...